Cellix Bio Private Limited, a active private limited company, was established on 21 May 2014 in Tirumalagiri, Telangana, India. Engaging in drug formulation & development within the pharma sector, it holds CIN: U74900TG2014PTC094095. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹23.10 Cr and a paid-up capital of ₹22.47 Cr.
It upholds a compliant status. Its leadership includes Achanna Chowdary Valluri (Director), Mahesh Kandula (Director), Subramaniam Apparsundaram (Director). Past directors included Nagendra Naidu Nutanapati, Mahesh Kandula, Apparsundram Rajanikanth. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Bc-08 , Ground Floor,Block B, Indu Fortune Annexe,, Phase 13, Kukatpally, Tirumalagiri, Telangana, 500085.
U74900TG2014PTC094095
094095
21 May 2014
₹23.10 Cr
₹22.47 Cr
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Cellix Bio Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Achanna Chowdary Valluri | Director | 21 May 2014 | Current |
| Mahesh Kandula | Director | 01 Oct 2014 | Current |
| Subramaniam Apparsundaram | Director | 06 Oct 2017 | Current |
| Sridhar Koganti | Director | 27 Dec 2023 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Company Secretary | 31 May 2024 | Past |
| Pramod Abcsdd | Whole-Time Director | 26 Dec 2017 | Past |
| Pramod Abcsdd | Additional Director | 06 Sep 2022 | Past |
| Pramod Abcsdd | Company Secretary | - | Past |
| Pramod Abcsdd | Additional Director | 06 Dec 2023 | Past |
| Pramod Abcsdd | Secretary | - | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Cellix Bio Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 44.3% decrease. The company also saw a substantial improvement in profitability, with a 41.77% increase in profit. The company's net worth Soared by an impressive increase of 16.05%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2020, Cellix Bio had a promoter holding of 97.41% and a public holding of 2.59%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Cellix Bio, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Cellix Bio, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cellix Bio's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Anshul Jain was appointed as a Company Secretary was appointed as a Company Secretary on 03 Oct 2025 & has been associated with this company since 1 month 22 days . was completed.
Progress on Cellix Bio Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
The activity Cellix Bio Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad. was completed.
Sridhar Koganti was appointed as a Director was appointed as a Director on 27 Dec 2023 & has been associated with this company since 1 year 11 months . was recorded as a recent event.
Subramaniam Apparsundaram was appointed as a Director was appointed as a Director on 06 Oct 2017 & has been associated with this company since 8 years 1 month . was recorded as a recent event.
Mahesh Kandula was appointed as a Director was appointed as a Director on 01 Oct 2014 & has been associated with this company since 11 years 1 month . was recorded as a recent event.
The CIN of Cellix Bio Private Limited is U74900TG2014PTC094095.
Cellix Bio Private Limited is headquartered at Bc-08 , Ground Floor,Block B, Indu Fortune Annexe,, Phase 13, Kukatpally, Tirumalagiri, Telangana, 500085.
Cellix Bio Private Limited was incorporated on 21 May 2014.
The current directors of Cellix Bio Private Limited are
The primary industry of Cellix Bio Private Limited is Pharma.
Cellix Bio Private Limited is unlisted.
The authorized capital of Cellix Bio Private Limited is ₹23.10 Cr, and the paid-up capital is ₹22.47 Cr.
The compliance status of Cellix Bio Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX